Biologics in Inflammatory Bowel Disease, An issue of Gastroenterology Clinics of North America, E-Book

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Gastroenterology, Ailments & Diseases, Diseases
Cover of the book Biologics in Inflammatory Bowel Disease, An issue of Gastroenterology Clinics of North America, E-Book by Edward V. Loftus, Jr, MD, Elsevier Health Sciences
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Edward V. Loftus, Jr, MD ISBN: 9780323323260
Publisher: Elsevier Health Sciences Publication: August 21, 2014
Imprint: Elsevier Language: English
Author: Edward V. Loftus, Jr, MD
ISBN: 9780323323260
Publisher: Elsevier Health Sciences
Publication: August 21, 2014
Imprint: Elsevier
Language: English

By the time this issue of Gastroenterology Clinics of North America is released, it will have been 16 years since infliximab was approved by the US Food and Drug Administration for the treatment of moderate to severe Crohn disease. Not only have we come a long way in understanding the efficacy and safety of infliximab, we are beginning to understand how and when to use the drug. Furthermore, as of this writing, we have five other biologic agents approved for either Crohn disease or ulcerative colitis, and there are many more molecules currently in drug development for these indications. In this issue,the Editors have assembled a collection of experts to provide the most cutting-edge information on the status of biologic therapy for inflammatory bowel disease.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

By the time this issue of Gastroenterology Clinics of North America is released, it will have been 16 years since infliximab was approved by the US Food and Drug Administration for the treatment of moderate to severe Crohn disease. Not only have we come a long way in understanding the efficacy and safety of infliximab, we are beginning to understand how and when to use the drug. Furthermore, as of this writing, we have five other biologic agents approved for either Crohn disease or ulcerative colitis, and there are many more molecules currently in drug development for these indications. In this issue,the Editors have assembled a collection of experts to provide the most cutting-edge information on the status of biologic therapy for inflammatory bowel disease.

More books from Elsevier Health Sciences

Cover of the book Sporting Injuries to the Foot & Ankle, An Issue of Foot and Ankle Clinics, E-Book by Edward V. Loftus, Jr, MD
Cover of the book Abdominal Ultrasound, An Issue of Ultrasound Clinics, E-Book by Edward V. Loftus, Jr, MD
Cover of the book Fundamentals of Urine and Body Fluid Analysis - E-Book by Edward V. Loftus, Jr, MD
Cover of the book Undergraduate Manual of Clinical Cases in Paediatrics - E-book by Edward V. Loftus, Jr, MD
Cover of the book Chinesische Zungendiagnostik by Edward V. Loftus, Jr, MD
Cover of the book The Energetics of Health E-Book by Edward V. Loftus, Jr, MD
Cover of the book Colorectal Surgery E-Book by Edward V. Loftus, Jr, MD
Cover of the book Update on Imaging Contrast Agents, An Issue of Magnetic Resonance Imaging Clinics of North America, E-Book by Edward V. Loftus, Jr, MD
Cover of the book Recombinant DNA and biotechnology by Edward V. Loftus, Jr, MD
Cover of the book Endoscopic Ear Surgery, an Issue of Otolaryngologic Clinics, E-Book by Edward V. Loftus, Jr, MD
Cover of the book Hacker & Moore's Essentials of Obstetrics and Gynecology E-Book by Edward V. Loftus, Jr, MD
Cover of the book Health and Health Care Delivery in Canada - E-Book by Edward V. Loftus, Jr, MD
Cover of the book Textbook of Oral Medicine, Oral Diagnosis and Oral Radiology - E-Book by Edward V. Loftus, Jr, MD
Cover of the book Metabolism of amino acids by Edward V. Loftus, Jr, MD
Cover of the book Year Book of Ophthalmology 2014, E-Book by Edward V. Loftus, Jr, MD
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy